WASHINGTON (Reuters) - Women with locally advanced breast cancer who are overweight have a worst prognosis than their slimmer counterparts, U.S. researchers reported on Friday.
An aggressive type of breast cancer, known as inflammatory breast cancer, was also seen in significantly more obese and overweight patients than in normal-weight patients, according to the study, published in the journal Clinical Cancer Research.
"The more obese a patient is, the more aggressive the disease," said principal investigator Dr. Massimo Cristofanilli of the University of Texas M.D. Anderson Cancer Center in Houston. "We are learning that the fat tissue may increase inflammation that leads to more aggressive disease."
Cristofanilli and colleagues studied 602 women with locally advanced breast cancer. They classified the patients by body mass index (BMI), the ratio of height to weight, frequently used to measure obesity. (People with BMIs of less than 18.5 are underweight; between 18.5 and 24.9 is considered normal; 25.0 to 29.9 is overweight; and 30 or higher is obese.)
After 5 years, the researchers report that 58.6 percent of the obese women, 58.3 percent of the overweight women and 69.3 percent of the normal-weight women were still alive.
After 10 years, 57.3 percent of normal- or underweight had survived compared with 42.4 percent of obese women and 44.1 percent of overweight women.
"Obesity goes far beyond just how a person looks or any physical strain from carrying around extra weight. Particular attention should be paid to our overweight patients," Cristofanilli said.
Many studies have shown that the obese have a greater risk of several types of cancer. Last month British researchers reported in The Lancet medical journal that obesity can double the risk of leukemia, multiple myeloma, thyroid cancer, colon and kidney cancers.
Research News on Risk Factors
- Mom's Cancer Shows Up Earlier in Daughters
- Dense Breasts Hike Risk of Aggressive Cancer
- Young Cancer Survivors Face Lifelong Risk of More Cancers
- ASCO: BMI Fails to Predict Outcomes in Metastatic Breast Cancer
- ASCO: Exemestane Scores for Primary Prevention of Breast Cancer
More » (183 Articles)